- Home
- BCRX vs ARWR Comparison
BCRX vs ARWR Comparison
Compare BCRX & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- ARWR
- Stock Information
- Founded
- BCRX 1986
- ARWR 2003
- Country
- BCRX United States
- ARWR United States
- Employees
- BCRX N/A
- ARWR N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- BCRX Health Care
- ARWR Health Care
- Exchange
- BCRX Nasdaq
- ARWR Nasdaq
- Market Cap
- BCRX 1.9B
- ARWR 1.8B
- IPO Year
- BCRX 1994
- ARWR 1993
- Fundamental
- Price
- BCRX $8.66
- ARWR $16.55
- Analyst Decision
- BCRX Strong Buy
- ARWR Buy
- Analyst Count
- BCRX 10
- ARWR 8
- Target Price
- BCRX $16.70
- ARWR $43.71
- AVG Volume (30 Days)
- BCRX 3.2M
- ARWR 1.9M
- Earning Date
- BCRX 08-04-2025
- ARWR 08-07-2025
- Dividend Yield
- BCRX N/A
- ARWR N/A
- EPS Growth
- BCRX N/A
- ARWR N/A
- EPS
- BCRX N/A
- ARWR N/A
- Revenue
- BCRX $503,485,000.00
- ARWR $545,209,000.00
- Revenue This Year
- BCRX $38.50
- ARWR $22,384.93
- Revenue Next Year
- BCRX $10.04
- ARWR N/A
- P/E Ratio
- BCRX N/A
- ARWR N/A
- Revenue Growth
- BCRX 41.67
- ARWR 1436.97
- 52 Week Low
- BCRX $6.02
- ARWR $9.57
- 52 Week High
- BCRX $11.31
- ARWR $29.86
- Technical
- Relative Strength Index (RSI)
- BCRX 35.06
- ARWR 36.33
- Support Level
- BCRX $8.40
- ARWR $17.59
- Resistance Level
- BCRX $8.79
- ARWR $19.33
- Average True Range (ATR)
- BCRX 0.25
- ARWR 1.07
- MACD
- BCRX -0.00
- ARWR -0.39
- Stochastic Oscillator
- BCRX 18.07
- ARWR 0.89
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.